Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1989-10-20
1991-03-05
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514 12, 514 13, A61K 3156, A61K 3700
Patent
active
049978250
ABSTRACT:
The concentration of endogenous growth hormone in the bloodstream of an economic mammal is increased by the simultaneous administration of an estrogen and a growth hormone releasing factor.
REFERENCES:
patent: 4670249 (1987-06-01), Ivy et al.
Chemical Abstracts (83:136918b) 1975.
Journal of Endocrinology, vol. 104, No. supplement, Mar. 1985, p. 45; C. A. Edwards et al.: "Interactions between GRF and Other Neuroregulators of GH Secretion" (abstract).
Eli Lilly and Company
Friedman Stanley J.
Page Kathleen R. S.
Weddington Kevin
Whitaker Leroy
LandOfFree
Synergistic treatment method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic treatment method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic treatment method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-496884